Amgen to Start Construction of a New Bio Manufacturing Facility in the USA
Introduction:
Amgen has unveiled its plans to build a new biomanufacturing plant in Holly Springs, North Carolina, in the United States.
Features:
The facility will be essential in meeting the rising demand for pharmaceuticals that can save lives and treat a variety of major ailments, including cancer and heart disease.
Amgen is making a lot of effort to increase productivity and make sure it can create the wide variety of medications it offers to patients.
The company's aim of reducing water usage, waste production, and reaching carbon neutrality by 2027 will be adhered to by the new facility, which is being developed with sustainability as a top focus. It will be constructed to satisfy the highest environmental requirements.
Integrated Project Services, LLC is in charge of the construction management, and design of this new facility.
It is estimated that the facility will be in use by 2025.
Specifications:
| Name | Amgen |
| Type | New Construction |
| Year | 2025 |
